Search - tctmd.com

Displaying 21 - 29 of 29

Sort: Relevancy | Date

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT 2023

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

Presenter: Muath Bishawi

March 21, 2023

Presentation THT 2023

Impella as a Bridge-to-Closure in Post-Infarction Ventricular Septal Defect

Presenter: Sandeep Jalli

March 21, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Presenter: Arman Kilic

March 20, 2023

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Selective Use of PAC and Impella for Managing Shock is Best For Patients

Presenter: Sunil Rao

February 02, 2022

Presentation THT 2022

Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO In Acute Myocardial Infarction

Presenter: Kay Everett

February 01, 2022

Advertisement

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

Impella as a Bridge-to-Closure in Post-Infarction Ventricular Septal Defect

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Selective Use of PAC and Impella for Managing Shock is Best For Patients

Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO In Acute Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content